Several large-scale cancer genome analyses showed that of all common oncogenic mutations, aneuploidy most strongly correlates with mutations in the TP53 gene (Taylor et al. 2018; Donehower et al. 2019; Hoadley et al. 2014; Ciriello et al. 2013; Davoli et al. 2017; Zack et al. 2013). Here, TP53 is linked to cancer.